CA2074081A1 - Cytotoxic cell-specific protease-related molecules and methods - Google Patents

Cytotoxic cell-specific protease-related molecules and methods

Info

Publication number
CA2074081A1
CA2074081A1 CA 2074081 CA2074081A CA2074081A1 CA 2074081 A1 CA2074081 A1 CA 2074081A1 CA 2074081 CA2074081 CA 2074081 CA 2074081 A CA2074081 A CA 2074081A CA 2074081 A1 CA2074081 A1 CA 2074081A1
Authority
CA
Canada
Prior art keywords
cells
cell
cytotoxic
protease
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2074081
Other languages
English (en)
French (fr)
Inventor
Robert C. Bleackley
Corrine G. Lobe
Verner H. Paetkau
Michael N. G. James
Michael Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seragen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2074081A1 publication Critical patent/CA2074081A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA 2074081 1990-01-19 1991-01-17 Cytotoxic cell-specific protease-related molecules and methods Abandoned CA2074081A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46788090A 1990-01-19 1990-01-19
US467,880 1990-01-19

Publications (1)

Publication Number Publication Date
CA2074081A1 true CA2074081A1 (en) 1991-07-20

Family

ID=23857533

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2074081 Abandoned CA2074081A1 (en) 1990-01-19 1991-01-17 Cytotoxic cell-specific protease-related molecules and methods

Country Status (4)

Country Link
EP (1) EP0511302A4 (ja)
JP (1) JPH05506569A (ja)
CA (1) CA2074081A1 (ja)
WO (1) WO1991010685A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858758A (en) * 1997-05-07 1999-01-12 Incyte Pharmaceuticals, Inc. Human serine protease precursor
EP1075485A4 (en) * 1998-05-05 2004-12-15 Gene Logic Inc METHOD FOR STUDYING MODIFICATIONS OF GENE EXPRESSION IN T CELLS
AU2003275173A1 (en) * 2002-09-25 2004-04-19 Board Of Regents, The University Of Texas System Endogenous granzyme b in human non-hematopoietic cells
US20160257710A1 (en) * 2013-11-04 2016-09-08 Inserm (Institut National De La Santé Et La Recherche Médicale) Selective inhibitors of proteinase 3

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783410A (en) * 1985-06-28 1988-11-08 Massachusetts Institute Of Technology Cytotoxic t lymphocyte serine esterase and method for stimulation and inhibition
EP0300033B1 (en) * 1987-01-13 1994-11-17 Seragen, Inc. Cytotoxic lymphocyte-specific protease-related molecules and methods

Also Published As

Publication number Publication date
EP0511302A1 (en) 1992-11-04
EP0511302A4 (en) 1993-05-05
WO1991010685A1 (en) 1991-07-25
JPH05506569A (ja) 1993-09-30

Similar Documents

Publication Publication Date Title
Gershenfeld et al. Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte
Mueller et al. A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor.
Lobe et al. Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes.
Griffiths et al. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells
US5602102A (en) Dipeptidyl peptidase-I inhibitors and uses thereof
US5527884A (en) Mediators of chronic allograft rejection and DNA molecules encoding them
JP2001525666A (ja) ヒトセリンプロテアーゼ前駆体
US5869633A (en) Thrombin receptor homolog polynucleotide
Whiting et al. Expression of angiotensin converting enzyme mRNA in rat brain
Lobe et al. Organization of two genes encoding cytotoxic T lymphocyte-specific serine proteases CCPI and CCPII
CA2074081A1 (en) Cytotoxic cell-specific protease-related molecules and methods
JPH05184387A (ja) Ｃｄ８＋ ｔリンパ球のサブポピュレーション中に見出される細胞内抗原及びそれに対するモノクローナル抗体
US4973555A (en) Human serine protease gene
EP0300033B1 (en) Cytotoxic lymphocyte-specific protease-related molecules and methods
EP0245051B1 (en) Killer cell cytotoxic composition
Simon et al. Induction of T cell serine proteinase 1 (TSP‐1)‐specific mRNA in mouse T lymphocytes
AU720749B2 (en) New cathepsin C homolog
US7247438B1 (en) Methods of identifying agents which enhance caspase activity
US5213977A (en) Serine protease from cytotoxic killer cells
JP2002505589A (ja) 新規のヒトリゾホスホリパーゼ
Hershberger et al. A serine protease-encoding gene that marks activated cytotoxic T cells in vivo and in vitro
AU687751B2 (en) Compositions for the inhibition of protein hormone formation and uses therof
Bleackley et al. A molecular-genetic analysis of cytotoxic T lymphocyte function
Vivo RJ HERSHBERGER, C. MUELLER, HK GERSHENFELD, and IL WEISSMAN
CN1978642A (zh) 人hLDP基因序列、其编码蛋白及制备方法

Legal Events

Date Code Title Description
FZDE Dead